<DOC>
	<DOCNO>NCT00590629</DOCNO>
	<brief_summary>Several risk factor include high cholesterol contribute heart disease . We know lower triglyceride raise HDL ( protective cholesterol ) men reduce risk heart disease . We expect woman share benefit combination high triglyceride low HDL appear important risk heart disease woman . Niacin reduce triglyceride raise HDL . We also expect see improvement marker inflammation clot formation blood vessel health , hypothesize confer reduce risk heart disease woman . Women already take lipid lower statin receive niacin therapy . We measure blood lipid level , marker inflammation clot well non-invasive measure blood vessel reactivity . After 3 month therapy repeat measure .</brief_summary>
	<brief_title>Benefit Elevation HDL-C Cardiovascular Outcomes Women</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Stable woman statin therapy LDLC 90135mg/dl triglyceride &gt; 150mg/dl History MI , PTCA surgery within previous 3 month Currently Niaspan unwilling withdraw Niaspan therapy know intolerance niacin Active know gall bladder disease Pregnant nursing woman Significant comorbidity precludes participation Significant liver disease , active alcoholism , LFT &gt; 1.5x 's ULN screening Diabetes glucose &gt; 126 mg/dl screen PI perceive inability comply protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Women without CAD</keyword>
</DOC>